While patients who undergo percutaneous closure of ventricular septal defect (VSD) have a high rate of in-hospital mortality, long-term outcomes are generally favorable in those who survive to ...

BOSTON, MA—Rare, postinfarction ventricular septal defects (VSDs), which saw a worrisome resurgence during the COVID-19 pandemic, can effectively be treated surgically or percutaneously, with similar ...

Percutaneous closure can be described as a less-invasive surgical procedure used to treat patients with atrial septal defect (ASD) or patent foramen ovale (PFO). Since the utilization of percutaneous ...

GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced its development program for PerQseal ® ...

Atrial septal defects (ASDs) are the second most common type of congenital heart disease. The most frequent variant of ASD, the ostium secundum (OS) type, results from deficiency of the flap valve of ...